Italian validation of the credibility/expectancy questionnaire in spinal pain: a useful tool for clinicians and physiotherapist (CEQ-I).

IF 2.8 3区 医学 Q2 PHARMACOLOGY & PHARMACY
Therapeutic Advances in Chronic Disease Pub Date : 2025-06-21 eCollection Date: 2025-01-01 DOI:10.1177/20406223251324812
Teresa Paolucci, Laura Belinda Rizzo, Giulia Patacchia, Chiara Sebastiani, Luca Furcas, Francesca Capuano, Marco Paoloni, Marta Di Nicola, Letizia Pezzi, Paola Borrelli
{"title":"Italian validation of the credibility/expectancy questionnaire in spinal pain: a useful tool for clinicians and physiotherapist (CEQ-I).","authors":"Teresa Paolucci, Laura Belinda Rizzo, Giulia Patacchia, Chiara Sebastiani, Luca Furcas, Francesca Capuano, Marco Paoloni, Marta Di Nicola, Letizia Pezzi, Paola Borrelli","doi":"10.1177/20406223251324812","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The \"credibility\" and \"expectation\" regarding the treatment are important factors in the rehabilitation management of patients with spinal pain (SP).</p><p><strong>Objectives: </strong>The aim of this study was to translate, culturally adapt, and validate an Italian version of the credibility/expectancy questionnaire (CEQ-I) by Devilly and Borkovec (CEQ) for its application in SP in rehabilitative care.</p><p><strong>Design: </strong>Cross-sectional observational study.</p><p><strong>Methods: </strong>Ninety-nine patients (<i>N</i> = 99; mean age of 56.9 years ± 16.3 SD) with acute or chronic SP were recruited from September 2023 to September 2024. To evaluate construct validity, exploratory factor analysis (EFA) was conducted using a matrix of polychoric correlations along with promax rotation. The internal consistency and stability of the scale were evaluated using Cronbach's alpha coefficient and test-retest analysis through the intraclass correlation coefficient (ICC). Pearson's analysis between CEQ and other scales (Numeric Rating Scale, NRS; Roland and Morris-Disability Questionnaire, RMDQ; Oswestry Disability Index, ODI; Neuropathic Pain Symptom Inventory, NPSI) was employed to assess external validity.</p><p><strong>Results: </strong>Ninety-nine subjects were recruited. Test-retest reliability between two consecutive administrations of the CEQ showed an ICC of 0.90 (<i>p</i> < 0.001). The Kaiser-Meyer-Olkin (KMO) statistic was 0.81, indicating suitability for factor analysis. EFA revealed two factors-credibility and expectancy-accounting for 56.6% of the variance. Cronbach's alpha indicated high internal consistency (0.85). External validation using Pearson's correlation found no significant relationships between the CEQ subscale scores and NRS, RMDQ, ODI, and NPSI scales.</p><p><strong>Conclusion: </strong>The CEQ-I is a valid Italian translation of CEQ that demonstrates acceptable psychometric properties in SP in a rehabilitative setting. However, we recommend further analysis of the construct definition of the CEQ-I.</p>","PeriodicalId":22960,"journal":{"name":"Therapeutic Advances in Chronic Disease","volume":"16 ","pages":"20406223251324812"},"PeriodicalIF":2.8000,"publicationDate":"2025-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12182615/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Chronic Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/20406223251324812","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The "credibility" and "expectation" regarding the treatment are important factors in the rehabilitation management of patients with spinal pain (SP).

Objectives: The aim of this study was to translate, culturally adapt, and validate an Italian version of the credibility/expectancy questionnaire (CEQ-I) by Devilly and Borkovec (CEQ) for its application in SP in rehabilitative care.

Design: Cross-sectional observational study.

Methods: Ninety-nine patients (N = 99; mean age of 56.9 years ± 16.3 SD) with acute or chronic SP were recruited from September 2023 to September 2024. To evaluate construct validity, exploratory factor analysis (EFA) was conducted using a matrix of polychoric correlations along with promax rotation. The internal consistency and stability of the scale were evaluated using Cronbach's alpha coefficient and test-retest analysis through the intraclass correlation coefficient (ICC). Pearson's analysis between CEQ and other scales (Numeric Rating Scale, NRS; Roland and Morris-Disability Questionnaire, RMDQ; Oswestry Disability Index, ODI; Neuropathic Pain Symptom Inventory, NPSI) was employed to assess external validity.

Results: Ninety-nine subjects were recruited. Test-retest reliability between two consecutive administrations of the CEQ showed an ICC of 0.90 (p < 0.001). The Kaiser-Meyer-Olkin (KMO) statistic was 0.81, indicating suitability for factor analysis. EFA revealed two factors-credibility and expectancy-accounting for 56.6% of the variance. Cronbach's alpha indicated high internal consistency (0.85). External validation using Pearson's correlation found no significant relationships between the CEQ subscale scores and NRS, RMDQ, ODI, and NPSI scales.

Conclusion: The CEQ-I is a valid Italian translation of CEQ that demonstrates acceptable psychometric properties in SP in a rehabilitative setting. However, we recommend further analysis of the construct definition of the CEQ-I.

意大利验证可信性/期望问卷在脊柱疼痛:临床医生和物理治疗师(CEQ-I)的有用工具。
背景:对治疗的“可信度”和“期望”是影响脊柱疼痛(SP)患者康复管理的重要因素。目的:本研究的目的是翻译,文化适应,并验证意大利语版的可信度/期望问卷(CEQ- i)由Devilly和Borkovec (CEQ)在SP康复护理中的应用。设计:横断面观察性研究。方法:99例患者(N = 99;在2023年9月至2024年9月期间招募了平均年龄56.9岁±16.3 SD的急性或慢性SP患者。为了评估建构的效度,探索性因子分析(EFA)采用多元相关矩阵和最大旋转。采用Cronbach’s alpha系数评价量表的内部一致性和稳定性,通过类内相关系数(intraclass correlation coefficient, ICC)进行重测分析。CEQ与其他量表(数字评定量表,NRS;Roland & morris伤残问卷;RMDQ;Oswestry残疾指数;采用神经性疼痛症状量表(NPSI)评估外效度。结果:共招募99名受试者。连续两次给药CEQ的重测信度显示ICC为0.90 (p < 0.001)。KMO (Kaiser-Meyer-Olkin)统计量为0.81,适合因子分析。EFA揭示了两个因素——可信度和期望——占方差的56.6%。Cronbach’s alpha表明内部一致性高(0.85)。使用Pearson相关的外部验证发现CEQ子量表得分与NRS、RMDQ、ODI和NPSI量表之间没有显著的关系。结论:CEQ- 1是CEQ的有效意大利语翻译,显示了康复环境中SP的可接受的心理测量特性。然而,我们建议进一步分析CEQ-I的结构定义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Therapeutic Advances in Chronic Disease
Therapeutic Advances in Chronic Disease Medicine-Medicine (miscellaneous)
CiteScore
6.20
自引率
0.00%
发文量
108
审稿时长
12 weeks
期刊介绍: Therapeutic Advances in Chronic Disease publishes the highest quality peer-reviewed research, reviews and scholarly comment in the drug treatment of all chronic diseases. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers involved in the medical treatment of chronic disease, providing a forum in print and online for publishing the highest quality articles in this area.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信